This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014;64:83-103.Search in Google Scholar
Friedman DL, Meadows AT. Late effects of childhood cancer therapy. Pediatr Clin North Am 2002;49:1083-6.Search in Google Scholar
Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, et al. Long-term results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin’s lymphoma-a report from the children’s oncology group. J Clin Oncol 2012;30:3174-80.Search in Google Scholar
Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: Life-long risks and responsibilities. Nat Rev Cancer 2014;14:61-70.Search in Google Scholar
Sloan FA, Gelband H. The cancer burden in low-and middle-income countries and how it is measured. In: Cancer Control Opportunities in Low-and Middle-Income Countries 2007. United States: National Academies Press; 2007.Search in Google Scholar
Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007;109:2736-43.Search in Google Scholar
Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: Results of the FAB/LMB 96 international study. Br J Haematol 2008;141:840-7.Search in Google Scholar
Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from medical research council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001;113:103-14.Search in Google Scholar
Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial. Lancet Oncol 2013;14:199-209.Search in Google Scholar
Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-7.Search in Google Scholar
Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, et al. UKCCSG’s germ cell tumour (GCT) studies: Improving outcome for children with malignant extracranial non-gonadal tumourscarboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom children’s cancer study group. Med Pediatr Oncol 1998;30:217-27.Search in Google Scholar
Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms’ tumor: The SIOP studies. International society of pediatric oncology. Urol Clin North Am 2000;27:443-54.Search in Google Scholar
Green DM. The treatment of stages I-IV favorable histology Wilms’ tumor. J Clin Oncol 2004;22:1366-72.Search in Google Scholar
Körholz D, Hamish W. Radiotherapy Manual; 2020. Available from: https://www.skion.nl/workspace/uploads/euronet-phl-c1_workingcopy_inkl_ amendm06_mw_2012-11-14_0.pdf. [Last accessed on 2020 May 01].Search in Google Scholar
Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, et al. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: Results from MRC UKALL XI and MRC ALL97 randomised trials. UK medical research council’s working party on childhood leukaemia. Leukemia 2000;14:356-63.Search in Google Scholar
Coppes MJ, Wolff JE, Ritchey ML. Wilms tumour: Diagnosis and treatment. Paediatr Drugs 1999;1:251-62.Search in Google Scholar
World Health Organization. Prevention of Blindness and Deafness: Grades of Hearing Impairment. Geneva: World Health Organization; 2011. Available from: http://www.who.int/pbd/deafness/hearing_impairment_grades/en/index.html. [Last accessed on 2011 July 01].Search in Google Scholar
MacIntyre N, Crapo R, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-35.Search in Google Scholar
Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: A retrospective study. BMC Endocr Disord 2008;8:15.Search in Google Scholar
Langer T, Grabow D, Steinmann D, Wörmann B, Calaminus G. Late effects and long-term follow-up after cancer in childhood. Oncol Res Treat 2017;40:746-50.Search in Google Scholar
Livinalli A, Silva MT, Lopes LC. Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer. Medicine (Baltimore) 2019;98:e14921.Search in Google Scholar
Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003;290:465-75.Search in Google Scholar
Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, et al. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer 2017;64:71-80.Search in Google Scholar
Chojnacka M, Pędziwiatr K, Skowrońska-Gardas A, Perek-Polnik M, Perek D, Olasek P. Second brain tumors following central nervous system radiotherapy in childhood. Br J Radiol 2014;87:20140211.Search in Google Scholar
Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The childhood cancer survivor study. J Natl Cancer Inst 2010;102:1083-95.Search in Google Scholar
Teepen JC, Kremer L, Ronckers CM, Van Leeuwen FE, Hauptmann M, Broeder VD, et al. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: Role of chemotherapy. J Clin Oncol 2017;35:2288-98.Search in Google Scholar
Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study. J Natl Cancer Inst 2007;99:790-800.Search in Google Scholar
Wasilewski-Masker K, Seidel KD, Leisenring W, Mertens AC, Shnorhavorian M, Ritenour CW, et al. Male infertility in long-term survivors of pediatric cancer: A report from the childhood cancer survivor study. J Cancer Surviv 2014;8:437-47.Search in Google Scholar
van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 2009;52:108-12.Search in Google Scholar
Da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, et al. Recovery of spermatogenesis after treatment for Hodgkin’s disease: Limiting dose of MOPP chemotherapy. J Clin Oncol 1984;2:571-7.Search in Google Scholar
Buchanan JD, Fairley KF, Barrie JU. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet 1975;306:156-7.Search in Google Scholar
Ramjaun A, AlDuhaiby E, Ahmed S, Wang L, Yu E, Nathan PC, et al. Echocardiographic detection of cardiac dysfunction in childhood cancer survivors: How long is screening required? Pediatr Blood Cancer 2015;62:2197-203.Search in Google Scholar
Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: A cross-sectional study from the St. Jude lifetime cohort. Ann Intern Med 2016;164:93-101.Search in Google Scholar
Hu H, Zhang W, Huang D, Yang Q, Li J, Gao Y. Cardiotoxicity of anthracycline (ANT) treatment in children with malignant tumors. Pediatr Hematol Oncol 2018;35:111-20.Search in Google Scholar
Kasteler R, Weiss A, Schindler M, Sommer G, Latzin P, von der Weid NX, et al. Long-term pulmonary disease among Swiss childhood cancer survivors. Pediatr Blood Cancer 2018;65:e26749.Search in Google Scholar
Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: A systematic review. Chest 2011;140:881-901.Search in Google Scholar
Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: Data from the childhood cancer survivor study. J Clin Endocrinol Metab 2000;85:3227-32.Search in Google Scholar
Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: A literature-based meta-analysis. Cancer 2011;117:5250-60.Search in Google Scholar
Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, et al. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: New paradigms for translational genomics. J Natl Cancer Inst 2014;106:dju044.Search in Google Scholar
Shimoda S, Horsman J, Furlong W, Barr R, de Camargo B. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil. J Pediatr Hematol Oncol 2008;30:563-70.Search in Google Scholar
Bava L, Johns A, Kayser K, Freyer DR. Cognitive outcomes among Latino survivors of childhood acute lymphoblastic leukemia and lymphoma: A cross-sectional cohort study using culturally competent, performance-based assessment. Pediatr Blood Cancer 2018;65:e26844.Search in Google Scholar
Clemens E, van der Kooi AL, Broer L, van Dulmenden Broeder E, Visscher H, Kremer L, et al. The influence of genetic variation on late toxicities in childhood cancer survivors: A review. Crit Rev Oncol Hematol 2018;126:154-67.Search in Google Scholar
Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, et al. Genetic determinants of ototoxicity during and after childhood cancer treatment: Protocol for the pancarelife study. JMIR Res Protoc 2019;8:e11868.Search in Google Scholar
Van der Kooi AL, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: A pan care life study protocol. BMC Cancer 2018;18:930.Search in Google Scholar
Zheng DJ, Sint K, Mitchell HR, Kadan-Lottick NS. Patterns and predictors of survivorship clinic attendance in a population-based sample of pediatric and young adult childhood cancer survivors. J Cancer Surviv 2016;10:505-13.Search in Google Scholar
Klosky JL, Cash DK, Buscemi J, Lensing S, Garces-Webb DM, Zhao W, et al. Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv 2008;2:225-32.Search in Google Scholar
